Huang Shaoxin

Dr. Huang Shaoxin

School of Basic Medicine, Jiujiang University
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in Aging
Verified
Journal Article
Open access
HSHuang Shaoxin
Huang Shaoxin
BZBiyu Zhang
Biyu Zhang
WFWenyan Fan
Wenyan Fan
QZQihan Zhao
Qihan Zhao
LYLei Yang
Lei Yang
DFDenggang Fu
Denggang Fu
The tumor microenvironment (TME) has a strong influence on the progression, therapeutic response, and clinical outcome of acute myeloid leukemia (AML), one of the most common hematopoietic malignancies in adults. In this study, we identified TME-related genes associated with AML prognosis. Gene expression profiles from AML patients were downloaded from TCGA database, and immune and stromal scores were calculated using the ESTIMATE algorithm. Immune scores were correlated with clinical features such as FAB subtypes and patient's age. After categorizing AML cases into high and low score groups, an association between several differentially expressed genes (DEGs) and overall survival was identified. Functional enrichment analysis of the DEGs showed that they were primarily enriched in the immune response, inflammatory response, and cytokine activity, and were involved in signaling processes related to hematopoietic cell lineage, B cell receptor, and chemokine pathways. Two significant modules, dominated respectively by CCR5 and ITGAM nodes, were identified from the PPI network, and 20 hub genes were extracted. A total of 112 DEGs correlated with poor overall survival of AML patients, and 11 of those genes were validated in a separate TARGET-AML cohort. By identifying TME-associated genes, our findings may lead to improved prognoses and therapies for AML.

1 August 2023 in International Journal of Surgery
Verified
Journal Article
Open access
YWYu Wang
Yu Wang
LCLin Chen
Lin Chen
CYChengye Yao
Chengye Yao
TWTingting Wang
Tingting Wang
JWJing Wu
Jing Wu
SYShanglong Yao
Shanglong Yao
Background: Early recognition of the risk of acute respiratory distress syndrome (ARDS) after cardiopulmonary bypass (CPB) may improve clinical outcomes. The main objective of this study was to identify proteomic biomarkers and develop an early prediction model for CPB-ARDS. Methods: The authors conducted three prospective nested cohort studies of all consecutive patients undergoing cardiac surgery with CPB at Union Hospital of Tongji Medical College Hospital. Plasma proteomic profiling was performed in ARDS patients and matched controls (Cohort 1, April 2021–July 2021) at multiple timepoints: before CPB (T1), at the end of CPB (T2), and 24 h after CPB (T3). Then, for Cohort 2 (August 2021–July 2022), biomarker expression was measured and verified in the plasma. Furthermore, lung ischemia/reperfusion injury (LIRI) models and sham-operation were established in 50 rats to explore the tissue-level expression of biomarkers identified in the aforementioned clinical cohort. Subsequently, a machine learning-based prediction model incorporating protein and clinical predictors from Cohort 2 for CPB-ARDS was developed and internally validated. Model performance was externally validated on Cohort 3 (January 2023–March 2023). Results: A total of 709 proteins were identified, with 9, 29, and 35 altered proteins between ARDS cases and controls at T1, T2, and T3, respectively, in Cohort 1. Following quantitative verification of several predictive proteins in Cohort 2, higher levels of thioredoxin domain containing 5 (TXNDC5), cathepsin L (CTSL), and NPC intracellular cholesterol transporter 2 (NPC2) at T2 were observed in CPB-ARDS patients. A dynamic online predictive nomogram was developed based on three proteins (TXNDC5, CTSL, and NPC2) and two clinical risk factors (CPB time and massive blood transfusion), with excellent performance (precision: 83.33%, sensitivity: 93.33%, specificity: 61.16%, and F1 score: 85.05%). The mean area under the receiver operating characteristics curve (AUC) of the model after 10-fold cross-validation was 0.839 (95% CI: 0.824–0.855). Model discrimination and calibration were maintained during external validation dataset testing, with an AUC of 0.820 (95% CI: 0.685–0.955) and a Brier Score of 0.177 (95% CI: 0.147–0.206). Moreover, the considerably overexpressed TXNDC5 and CTSL proteins identified in the plasma of patients with CPB-ARDS, exhibited a significant upregulation in the lung tissue of LIRI rats. Conclusions: This study identified several novel predictive biomarkers, developed and validated a practical prediction tool using biomarker and clinical factor combinations for individual prediction of CPB-ARDS risk. Assessing the plasma TXNDC5, CTSL, and NPC2 levels might identify patients who warrant closer follow-up and intensified therapy for ARDS prevention following major surgery.

9 June 2022 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
XWXichen Wan
Xichen Wan
ZXZelong Xing
Zelong Xing
JOJin Ouyang
Jin Ouyang
HLHui Liu
Hui Liu
CCChengquan Cheng
Chengquan Cheng
HSHuang Shaoxin
Huang Shaoxin
Long-term exposure to cadmium (Cd) can severely damage the kidney, where orally absorbed Cd accumulates. However, the molecular mechanisms of Cd-induced kidney damage, especially the early biomarkers of Cd-induced renal carcinogenesis, are unclear. In the present study, we established a rat kidney injury model by intragastric administration of Cd to evaluate the morphological and biochemical aspects of kidney injury. We randomly divided Sprague-Dawley rats into control, low Cd (3 mg/kg), and high Cd (6 mg/kg) groups and measured biochemical indices associated with renal toxicity after 2, 4, and 8 weeks of treatment. The Cd-exposed mice had significantly higher Cd concentrations in blood and renal tissues as well as blood urea nitrogen (BUN), β2-microglobulin (β2-MG), urinary protein excretion, and tumor necrosis factor-α (TNF-α) levels. Furthermore, histopathological and transmission electron microscopy (TEM) observations revealed structural disruption of renal tubules and glomeruli after 8 weeks of exposure to the high Cd regimen. Besides, microarray technology experiments showed that Cd increased the expression of genes related to the chemical carcinogenesis pathway in kidney tissue. Finally, combining the protein–protein interaction (PPI) network of the Cd carcinogenesis pathway genes with the microarray and Comparative Toxicogenomics Database (CTD) results revealed two overlapping genes, CYP1B1 and UGT2B. Therefore, the combined molecular and bioinformatics experiments’ results suggest that CYP1B1 and UGT2B are biomarkers of Cd-induced kidney injury with precancerous lesions.

1 January 2019 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
LYLei Yang
Lei Yang
LLLanjie Lei
Lanjie Lei
QZQihan Zhao
Qihan Zhao
YGYing Gong
Ying Gong
GGGaopeng Guan
Gaopeng Guan
HSHuang Shaoxin
Huang Shaoxin
Yang L, et al. World J Mens Health. 2018 Jan;36:e39. https://doi.org/10.5534/wjmh.180041

1 May 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SWSheng Wan
Sheng Wan
YYYong Yang
Yong Yang
QZQihan Zhao
Qihan Zhao
ZXZelong Xing
Zelong Xing
JLJie Li
Jie Li
HSHuang Shaoxin
Huang Shaoxin
Emerging evidence implicates environmental contaminants such as cadmium (Cd) as modifiable risk factors for anxiety. Despite growing recognition of heavy metal toxicity in neuropsychiatric disorders, the molecular mechanisms linking environmental exposure to anxiety pathogenesis remain poorly understood. Based on the established cohort of individuals with cognitive impairment in cadmium-contaminated areas, this cross-sectional association study enrolled 50 middle-aged and elderly hospitalized patients from these regions, adhering to the STROBE guidelines. Blood concentrations of cadmium (Cd), lead (Pb), and mercury (Hg) were analyzed in relation to anxiety severity assessed via the Hamilton Anxiety Rating Scale (HAMA). Plasma proteomic profiling was performed using data-independent acquisition (DIA) quantitative technology with an LC–MS/MS platform (timsTOF Pro, Bruker Daltonics), systematically characterizing 2,531 proteins across all samples. Machine learning techniques, specifically XGBoost and LASSO, were employed to identify biomarkers that were subsequently validated through mediation analysis and animal experiments, allowing for the screening of key protein signatures. Finally, clinical variables were integrated to construct a comprehensive model, which was then thoroughly evaluated. Anxious individuals exhibited significantly higher blood Cd levels than controls (β = 0.50, 95% CI: 0.07–0.93, p < 0.01), with anxiety positively correlating with depression (r = 0.62, p = 0.003) and inversely with ApoE3 genotype prevalence. Proteomics identified 120 differentially expressed proteins in anxious patients, enriched in oxidative phosphorylation and neurodegenerative pathways. CCDC126 emerged as a cadmium-associated biomarker, validated in rat models exposed to Cd. Combining CCDC126, blood Cd, Pb, and hypertension, a clinical prediction model achieved robust discrimination (AUC = 0.80, validation cohort). This first integrative environmental-proteomic study highlights cadmium’s synergistic role in anxiety pathophysiology and psychiatric comorbidity. The predictive model offers translatable potential for early risk stratification, while CCDC126 provides mechanistic insights for targeted interventions in populations exposed to environmental pollutants. Integrating clinical and demographic data with plasma concentrations of heavy metals, this study developed a predictive model for the comorbidity of mental disorders in middle-aged and elderly individuals. Correlation analysis revealed significant links between plasma cadmium (Cd), lead (Pb), mercury (Hg), and anxiety. By utilizing the XGBoost and LASSO machine learning algorithms, combined with validation through animal experiments, CCDC126 was identified as a diagnostic biomarker derived from the plasma proteome. The clinical prediction model, which incorporates blood cadmium levels, hypertension status, protein expression, and blood lead concentration was formulated as: $$\left[ln\frac{P}{1-P}=-39.414+0.449\times Cd+1.896\times HYPERTENSION+3.586\times CCDC126-0.289\times Pb\right]$$ . The model achieved an Area Under the Curve (AUC) of 0.8, the model provides an early diagnostic tool for anxiety attributed to environmental pollutants and offers insights into geriatric psychiatric comorbidities.

23 March 2022 in Aging
Verified
Journal Article
Open access
PDF file
JOJin Ouyang
Jin Ouyang
ZHZhijian Hu
Zhijian Hu
JTJianlin Tong
Jianlin Tong
YYYong Yang
Yong Yang
JWJuan Wang
Juan Wang
HSHuang Shaoxin
Huang Shaoxin
Background: Lung cancer is a heterogeneous disease with a severe disease burden. Because the prognosis of patients with lung cancer varies, it is critical to identify effective biomarkers for prognosis prediction. Methods: A total of 2325 lung cancer patients were integrated into four independent sets (training set, validation set I, II and III) after removing batch effects in our study. We applied the microarray data algorithm to screen the differentially expressed genes in the training set. The most robust markers for prognosis were identified using the LASSO-Cox regression model, which was then used to create a Cox model and nomogram. Results: Through LASSO and multivariate Cox regression analysis, eight genes were identified as prognosis-associated hub genes, followed by the creation of prognosis-associated risk scores (PRS). The results of the Kaplan-Meier analysis in the three validation sets demonstrate the good predictive performance of PRS, with hazard ratios of 2.38 (95% confidence interval (CI), 1.61–3.53) in the validation set I, 1.35 (95% CI, 1.06–1.71) in the validation set II, and 2.71 (95% CI, 1.77–4.18) in the validation set III. Additionally, the PRS demonstrated superior survival prediction in subgroups by age, gender, p-stage, and histologic type (p < 0.0001). The complex model integrating PRS and clinical risk factors also have a good predictive performance for 3-year overall survival. Conclusions: In this study, we developed a PRS signature to help predict the survival of lung cancer. By combining it with clinical risk factors, a nomogram was established to quantify the individual risk assessments.